In Good Company with Nicolai Tangen cover image

Eli Lilly CEO: The Weight-Loss Drug Revolution, AI in Pharma, and Innovation

In Good Company with Nicolai Tangen

CHAPTER

Advancements in Diabetes Medications and Weight Management

This chapter highlights the unexpected benefits of diabetes medications like exenatide and terzepatide, particularly in relation to weight loss and overall health. It also delves into broader implications for chronic diseases and the societal factors contributing to the obesity epidemic.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner